||This article contains wording that promotes the subject in a subjective manner without imparting real information. (September 2010) (Learn how and when to remove this template message)|
ACell, Incorporated is a Columbia, Maryland-based biotechnology company. The company works in regenerative medicine, in which it owns several extracellular matrix patents. ACell develops, manufactures and markets products for medical and veterinary applications. The company is founded by Alan R. Spievack, a former associate professor at Harvard Medical School and currently run by Patrick A. McBrayer.
ACell's use of porcine cellular structure, called MatriStem, as a scaffold for human tissue regeneration was named the "medical breakthrough of the year" by Esquire. The use of pig bladder ground up into "magical pixie dust" to regrow Spievak's brother's finger received considerable mainstream coverage. Ken Muneoka of Tulane University, who works with ACell's scientific advisors on US-government funded investigations into regenerative medicine, said that the news should be viewed with caution because it was not a controlled study.
- "ACell wins extracellular matrix patent battle initiated by Cook Biotech and Purdue.". BIOTECH Patent News (August, 2006). 2006-08-01. Retrieved 2008-05-01.
- "Acell Inc. completes $6M round of financing". The Daily Record. 2004-03-23. Retrieved 2008-05-01.
- "Reborn, ACell enters medical wound healing". Maryland Gazette. Retrieved 2008-05-01.
- "No. 3: Medical Breakthrough of the Year". Esquire. Archived from the original on 8 May 2008. Retrieved 2008-05-01.
- "Man regrew finger - with pig powder?". New York Daily News. 2008-04-30. Archived from the original on 3 May 2008. Retrieved 2008-05-01.
- Price, Matthew (2008-04-30). "The man who grew a finger". BBC. Archived from the original on 5 May 2008. Retrieved 2008-05-01.